Xi Zheng

8.2k total citations · 1 hit paper
203 papers, 6.5k citations indexed

About

Xi Zheng is a scholar working on Molecular Biology, Cancer Research and Molecular Medicine. According to data from OpenAlex, Xi Zheng has authored 203 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Molecular Biology, 42 papers in Cancer Research and 28 papers in Molecular Medicine. Recurrent topics in Xi Zheng's work include Natural product bioactivities and synthesis (35 papers), Curcumin's Biomedical Applications (28 papers) and Cancer, Lipids, and Metabolism (21 papers). Xi Zheng is often cited by papers focused on Natural product bioactivities and synthesis (35 papers), Curcumin's Biomedical Applications (28 papers) and Cancer, Lipids, and Metabolism (21 papers). Xi Zheng collaborates with scholars based in China, United States and Poland. Xi Zheng's co-authors include Zhiyun Du, Chi Kwan Tsang, Kun Zhang, Yan He, Dongli Li, Yanjie Zhang, Allan H. Conney, Yuan Yue, Haiyan Qi and Leroy F. Liu and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Xi Zheng

197 papers receiving 6.4k citations

Hit Papers

Curcumin, Inflammation, and Chronic Diseases: How Are The... 2015 2026 2018 2022 2015 100 200 300 400

Peers

Xi Zheng
Madan M. Chaturvedi United States
Imtiaz A. Siddiqui United States
Manoj K. Pandey United States
Kyung‐Soo Chun South Korea
Haruyo Ichikawa United States
Madan M. Chaturvedi United States
Xi Zheng
Citations per year, relative to Xi Zheng Xi Zheng (= 1×) peers Madan M. Chaturvedi

Countries citing papers authored by Xi Zheng

Since Specialization
Citations

This map shows the geographic impact of Xi Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Zheng more than expected).

Fields of papers citing papers by Xi Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Zheng. The network helps show where Xi Zheng may publish in the future.

Co-authorship network of co-authors of Xi Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Zheng. A scholar is included among the top collaborators of Xi Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Zheng. Xi Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Hyung‐Goo, Mohammad Abdur Rashid, Faheem Ullah, et al.. (2025). Cognitive dysfunction in chemobrain: Molecular mechanisms and therapeutic implications. Biomedicine & Pharmacotherapy. 192. 118581–118581. 1 indexed citations
2.
Wang, Hui, Yiwen Wang, Yanfeng Zhang, et al.. (2024). Assessing IgG4-related autoimmune pancreatitis with contrast-enhanced ultrasonography based on time-intensity curve: a single-centre prospective study. Clinical and Experimental Rheumatology. 43(3). 410–417. 1 indexed citations
3.
Xu, Xuetao, et al.. (2023). Investigation on the inhibition mechanism and binding behavior of paeonol to tyrosinase and its anti-browning property by multi-spectroscopic and molecular docking methods. International Journal of Biological Macromolecules. 253(Pt 3). 126962–126962. 22 indexed citations
4.
Xu, Dan, Wenbo Zou, Wang Yao, et al.. (2023). Structure and anti-inflammatory activity of neo-clerodane diterpenoids from Scutellaria barbata. Phytochemistry. 213. 113771–113771. 3 indexed citations
5.
Zheng, Xi, et al.. (2022). Raman spectroscopy as a promising diagnostic method for rheumatoid arthritis. Analytical Methods. 15(6). 709–718. 7 indexed citations
6.
Li, Dongli, Yuanyuan Li, Li‐She Gan, et al.. (2022). Polysaccharides from Callerya speciosa alleviate metabolic disorders and gut microbiota dysbiosis in diet-induced obese C57BL/6 mice. Food & Function. 13(16). 8662–8675. 14 indexed citations
7.
Xu, Yao, Zhiwei Zhong, Yiwen Gao, et al.. (2021). The Mangrove-Derived Diterpenoid Diaporthe B Inhibits the Stemness and Increases the Efficacy of Docetaxel in Prostate Cancer PC-3 Cells. Natural Product Communications. 16(12).
8.
Wu, Jugang, et al.. (2021). δ-Tocopherol Enhances Docetaxel-Induced Growth Inhibition and Apoptosis in Ovarian Cancer SKOV3 Cells. Natural Product Communications. 16(3). 2 indexed citations
9.
Ren, Xiangshan, Xiao Wang, Xue-Tao Xu, et al.. (2021). Nobiletin Inhibits Cell Growth, Migration and Invasion, and Enhances the Anti-Cancer Effect of Gemcitabine on Pancreatic Cancer Cells. Natural Product Communications. 16(4). 2 indexed citations
10.
Ren, Xiangshan, Xue-Tao Xu, Panpan Wu, et al.. (2020). Nobiletin, a citrus polymethoxyflavone, enhances the effects of bicalutamide on prostate cancer cellsviadown regulation of NF-κB, STAT3, and ERK activation. RSC Advances. 10(17). 10254–10262. 19 indexed citations
11.
Sheng, Zhaojun, Fangying Xie, Bin Chen, et al.. (2020). Screening of larvicidal activity of 53 essential oils and their synergistic effect for the improvement of deltamethrin efficacy against Aedes albopictus. Industrial Crops and Products. 145. 112131–112131. 32 indexed citations
12.
Xu, Xue-Tao, Jie Chen, Kun Zhang, et al.. (2019). Synthesis and biological evaluation of coumarin derivatives as α-glucosidase inhibitors. European Journal of Medicinal Chemistry. 189. 112013–112013. 107 indexed citations
13.
Chen, Min, Hang Ma, Xi Zheng, et al.. (2019). Downregulating NF-κB signaling pathway with triterpenoids for attenuating inflammation:in vitroandin vivostudies. Food & Function. 10(8). 5080–5090. 27 indexed citations
14.
Jiang, Sen, Kun Zhang, Yan He, et al.. (2018). Synergistic effects and mechanisms of impressic acid or acankoreanogein in combination with docetaxel on prostate cancer. RSC Advances. 8(5). 2768–2776. 9 indexed citations
16.
Wang, Siyu, Joon Hyuk Suh, Wei‐Lun Hung, et al.. (2017). Use of UHPLC-TripleQ with synthetic standards to profile anti-inflammatory hydroxycinnamic acid amides in root barks and leaves of Lycium barbarum. Journal of Food and Drug Analysis. 26(2). 572–582. 32 indexed citations
17.
Zheng, Xi, et al.. (2017). Natural Products as Adjunctive Treatment for Pancreatic Cancer: Recent Trends and Advancements. BioMed Research International. 2017. 1–13. 64 indexed citations
18.
Wang, Siyu, Joon Hyuk Suh, Xi Zheng, Yu Wang, & Chi‐Tang Ho. (2016). Identification and Quantification of Potential Anti-inflammatory Hydroxycinnamic Acid Amides from Wolfberry. Journal of Agricultural and Food Chemistry. 65(2). 364–372. 63 indexed citations
19.
Wei, Rongrong, Guoliang Huang, Mei-Yin Zhang, et al.. (2013). Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma. Clinical Cancer Research. 19(17). 4780–4791. 88 indexed citations
20.
Conney, Allan H., George C. Wagner, Yong Lin, et al.. (2008). Inhibitory effect of voluntary running wheel exercise on the growth of human pancreatic Panc-1 and prostate PC-3 xenograft tumors in immunodeficient mice. Oncology Reports. 19(6). 1583–8. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026